3
SUMMARY
PharmEasy will raise fresh proceeds via NCD’s by pledging the shares of its listed diagnostic company Thyrocare
PharmEasy will use the fresh funds to clear the earlier debt which it raised via NCDs, with total outstanding redemption value of INR 1,820 Cr, of which the current outstanding is INR 1,545.4 Cr
This comes at a time when PharmEasy continues to struggle with profitability and has seen many leadership changes in recent times
API Holdings, the parent company of PharmEasy
, is planning to raise INR 1,700 Cr…
